Sign In
Buy CLB
$11.77
+0.0800 (+0.684%)
At Close: Jun 22, 2026
Fisher Asset Management LLC Sells 143,838 Shares of Core Laboratories Inc. $CLB
04:40am, Thursday, 04'th Dec 2025
Fisher Asset Management LLC lowered its position in shares of Core Laboratories Inc. (NYSE: CLB) by 14.2% during the undefined quarter, according to its most recent disclosure with the Securities and
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now
09:11am, Wednesday, 03'rd Dec 2025
CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties.
Tetra Technologies (NYSE:TTI) versus Core Laboratories (NYSE:CLB) Head to Head Review
02:14am, Tuesday, 02'nd Dec 2025
Tetra Technologies (NYSE: TTI - Get Free Report) and Core Laboratories (NYSE: CLB - Get Free Report) are both small-cap energy companies, but which is the superior investment? We will compare the two
Campbell & CO Investment Adviser LLC Takes Position in Core Laboratories Inc. $CLB
03:51am, Tuesday, 18'th Nov 2025
Campbell and CO Investment Adviser LLC acquired a new position in shares of Core Laboratories Inc. (NYSE: CLB) in the second quarter, according to its most recent disclosure with the Securities and Ex
Envestnet Asset Management Inc. Has $3.26 Million Stock Holdings in Core Laboratories Inc. $CLB
04:56am, Sunday, 16'th Nov 2025
Envestnet Asset Management Inc. boosted its holdings in shares of Core Laboratories Inc. (NYSE: CLB) by 11.4% in the undefined quarter, according to the company in its most recent 13F filing with the
Oppenheimer Asset Management Inc. Has $725,000 Stock Holdings in Core Laboratories Inc. $CLB
04:05am, Sunday, 02'nd Nov 2025
Oppenheimer Asset Management Inc. cut its holdings in shares of Core Laboratories Inc. (NYSE: CLB) by 9.0% during the undefined quarter, according to the company in its most recent filing with the Sec
Core Laboratories Q3 Earnings Surpass Estimates, Decline Y/Y
11:46am, Friday, 24'th Oct 2025
CLB beats Q3 earnings estimates on strong Production Enhancement results. However, earnings dip y/y due to the Reservoir Description segment's weakness.
Compelling Value In Small-Cap Equities And Select Cyclicals
11:45pm, Thursday, 23'rd Oct 2025
Supplier of residential thermal, comfort and security solutions, Resideo Technologies, Inc. (REZI) was the top contributor in the quarter. Shares of gold mining company, Barrick Mining Corporation (B)
Core Laboratories Inc. (CLB) Q3 2025 Earnings Call Transcript
11:10am, Thursday, 23'rd Oct 2025
Core Laboratories Inc. (NYSE:CLB ) Q3 2025 Earnings Call October 23, 2025 8:30 AM EDT Company Participants Lawrence Bruno - Chairman of the Board, CEO, President & COO Gwendolyn Schreffler - Senior Vi
Core Laboratories (CLB) Beats Q3 Earnings and Revenue Estimates
07:01pm, Wednesday, 22'nd Oct 2025
Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.25 per share a year ago.
CORE LAB REPORTS THIRD QUARTER 2025 RESULTS
05:00pm, Wednesday, 22'nd Oct 2025
HOUSTON, Oct. 22, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported third quarter 2025 revenue of $134,500,000. Core's operating income was $20,
Core Laboratories to Post Q3 Earnings: Key Metrics to Watch
12:21pm, Thursday, 16'th Oct 2025
CLB is set to post Q3 earnings amid volatile oil markets, with estimates hinting at lower revenues and profit declines.
Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy?
11:02am, Wednesday, 15'th Oct 2025
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in Core Laboratories (CLB): Can Its 6.0% Jump Turn into More Strength?
06:21am, Tuesday, 14'th Oct 2025
Core Laboratories (CLB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near
Here's Why Holding Core Laboratories Stock Is Justified for Now
09:46am, Monday, 06'th Oct 2025
CLB benefits from revenue expansion, proprietary tools & disciplined spending, though flat guidance, low dividends & sector competition remain headwinds.
